Woolcock AJ - Search Results

1

Nocturnal asthma: role of snoring and obstructive sleep apnea.

Chan CS, Woolcock AJ, Sullivan CE. Chan CS, et al. Among authors: woolcock aj. Am Rev Respir Dis. 1988 Jun;137(6):1502-4. doi: 10.1164/ajrccm/137.6.1502. Am Rev Respir Dis. 1988. PMID: 3059864

2

Eucapnia and hypercapnia in patients with chronic airflow limitation. The role of the upper airway.

Chan CS, Bye PT, Woolcock AJ, Sullivan CE. Chan CS, et al. Among authors: woolcock aj. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):861-5. doi: 10.1164/ajrccm/141.4_Pt_1.861. Am Rev Respir Dis. 1990. PMID: 2109557

3

Obstructive sleep apnea with severe chronic airflow limitation. Comparison of hypercapnic and eucapnic patients.

Chan CS, Grunstein RR, Bye PT, Woolcock AJ, Sullivan CE. Chan CS, et al. Among authors: woolcock aj. Am Rev Respir Dis. 1989 Nov;140(5):1274-8. doi: 10.1164/ajrccm/140.5.1274. Am Rev Respir Dis. 1989. PMID: 2817588

4

Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics.

Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Ollerenshaw SL, et al. Among authors: woolcock aj. Eur Respir J. 1991 Jun;4(6):673-82. Eur Respir J. 1991. PMID: 1716217

5

Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma.

Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T. Ollerenshaw S, et al. N Engl J Med. 1989 May 11;320(19):1244-8. doi: 10.1056/NEJM198905113201904. N Engl J Med. 1989. PMID: 2610738

6

Characteristics of bronchial hyperresponsiveness in chronic obstructive pulmonary disease and in asthma.

Woolcock AJ, Anderson SD, Peat JK, Du Toit JI, Zhang YG, Smith CM, Salome CM. Woolcock AJ, et al. Am Rev Respir Dis. 1991 Jun;143(6):1438-43. doi: 10.1164/ajrccm/143.6.1438. Am Rev Respir Dis. 1991. PMID: 2048834

7

Which index of peak expiratory flow is most useful in the management of stable asthma?

Reddel HK, Salome CM, Peat JK, Woolcock AJ. Reddel HK, et al. Among authors: woolcock aj. Am J Respir Crit Care Med. 1995 May;151(5):1320-5. doi: 10.1164/ajrccm.151.5.7735580. Am J Respir Crit Care Med. 1995. PMID: 7735580

8

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.

Jenkins C, Woolcock AJ, Saarelainen P, Lundback B, James MH. Jenkins C, et al. Among authors: woolcock aj. Respir Med. 2000 Jul;94(7):715-23. doi: 10.1053/rmed.2000.0875. Respir Med. 2000. PMID: 10926345 Free article. Clinical Trial.

9

Optimal asthma control, starting with high doses of inhaled budesonide.

Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, Badcock CA, Woolcock AJ. Reddel HK, et al. Among authors: woolcock aj. Eur Respir J. 2000 Aug;16(2):226-35. doi: 10.1034/j.1399-3003.2000.16b08.x. Eur Respir J. 2000. PMID: 10968496 Free article. Clinical Trial.

10

Toward a definition of asthma for epidemiology.

Toelle BG, Peat JK, Salome CM, Mellis CM, Woolcock AJ. Toelle BG, et al. Among authors: woolcock aj. Am Rev Respir Dis. 1992 Sep;146(3):633-7. doi: 10.1164/ajrccm/146.3.633. Am Rev Respir Dis. 1992. PMID: 1519839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page